Rankings / Mitochondria & Cellular Energy

CoQ10 (ubiquinone/ubiquinol)

Mitochondria & Cellular Energy · Electron transport cofactor

Also known as: Coenzyme Q10 ·Ubiquinol ·Ubiquinone

Tier A+

Reviewed by Read Off Label · Last reviewed · How we grade

mitochondrialantioxidantubiquinolstatin-myopathyotc
8.2 / 10
Tier A+
Ev 8 Bn 6.5 Sf 9

Bottom line

Read Off Label grades CoQ10 (ubiquinone/ubiquinol) as A+ (8.2/10) based on strong evidence, med-high benefit magnitude, and a low-risk safety profile.

Q-SYMBIO trial (Mortensen 2014, JACC HF): 3x100 mg ubiquinone x 2 yr in NYHA III-IV HF; 18% cardiovascular mortality reduction; ~42% reduction in MACE.

Typical use: 100-300 mg/day with fat-containing meal; ubiquinol form preferred for adults >50 (3-4x higher plasma CoQ10 in elderly… — OTC.

What this is

Q-SYMBIO trial (Mortensen 2014, JACC HF): 3x100 mg ubiquinone x 2 yr in NYHA III-IV HF; 18% cardiovascular mortality reduction; ~42% reduction in MACE. European subgroup analysis 2019 confirmed effect direction. 2024 systematic review of 16 studies replicated 40% HF-related mortality reduction signal. Depleted by statins via shared mevalonate pathway — consider for statin-induced muscle symptoms (2025 MA supports modest pain reduction). Endogenous levels decline with age, hence the elderly absorption argument for ubiquinol. **Ubiquinol vs ubiquinone caveat**: ubiquinol delivers ~3-4x higher plasma CoQ10 in adults >40 (more pronounced in elderly) per multiple bioavailability RCTs, but the strongest clinical outcome trials (Q-SYMBIO) used ubiquinone at 300 mg/day. Translation: if you're young/healthy, either form works; if you're >50 or have malabsorption or are post-MI/HF, ubiquinol is the better-justified choice.

Mechanism

Electron transport chain cofactor (complex III; mitochondrial ATP synthesis); lipid-soluble antioxidant in membranes and LDL; endogenous synthesis shares the mevalonate pathway with cholesterol — depleted by statins; ubiquinol = reduced/active form; ubiquinone = oxidized form (interconverted in vivo by NQO1 and other reductases)

Dose & route

100-300 mg/day with fat-containing meal; ubiquinol form preferred for adults >50 (3-4x higher plasma CoQ10 in elderly due to reduced NQO1 conversion capacity); pivotal RCTs (Q-SYMBIO) used ubiquinone — bioavailability advantage of ubiquinol does NOT automatically translate to superior outcomes

Citations

Links go to the source. If a link is dead or you want something re-checked, let me know.

Common questions

Does CoQ10 (ubiquinone/ubiquinol) work?
Read Off Label rates the evidence for CoQ10 (ubiquinone/ubiquinol) as Strong and the benefit magnitude as med-high, producing an overall grade of A+ (8.2/10). Q-SYMBIO trial (Mortensen 2014, JACC HF): 3x100 mg ubiquinone x 2 yr in NYHA III-IV HF; 18% cardiovascular mortality reduction; ~42% reduction in MACE.
Is CoQ10 (ubiquinone/ubiquinol) safe?
CoQ10 (ubiquinone/ubiquinol) has a low risk profile in published human data. Legal status: OTC. This is not medical advice — see the disclaimer.
What is the typical dose for CoQ10 (ubiquinone/ubiquinol)?
100-300 mg/day with fat-containing meal; ubiquinol form preferred for adults >50 (3-4x higher plasma CoQ10 in elderly due to reduced NQO1 conversion capacity); pivotal RCTs (Q-SYMBIO) used ubiquinone — bioavailability advantage of ubiquinol does NOT automatically translate to superior outcomes
How does CoQ10 (ubiquinone/ubiquinol) work?
Electron transport chain cofactor (complex III; mitochondrial ATP synthesis); lipid-soluble antioxidant in membranes and LDL; endogenous synthesis shares the mevalonate pathway with cholesterol — depleted by statins; ubiquinol = reduced/active form; ubiquinone = oxidized form (interconverted in vivo by NQO1 and other reductases)

This is an independent synthesis of published research by a non-clinician. Scores are opinions supported by citations, not prescriptions. See the full disclaimer and methodology for how this score was produced and what it does and doesn't mean.